PC p.Ala162Val
c.485C>T · rs752714051 · VCV664733
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2109 | likely benign |
|---|---|---|
| REVEL | 0.81 | moderately pathogenic-leaning |
| SaProt | LLR -12.75 | damaging |
| ⇒ REVEL and SaProt call this damaging; AlphaMissense does not. | ||
| Splicing | ||
| SpliceAI | Δ0.83 | donor gain · deltas |
| Pangolin | Δ0.47 | gain · loss 0.33 · agrees with SpliceAI · independent |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 1.3, phastCons 1 |
| Regional constraint | o/e 0.74 | unconstrained · MANE · 23 kb · p 3.1e-25 · regional, not allelic |
| Overall | ||
| CADD | 36.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.00223% | 44,886 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,506 |
| European (non-Finnish) | 0.0011% | 90,770 |
| South Asian | 0.0011% | 91,086 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PC
- Protein
- p.Ala162Val
- Coding
- c.485C>T
- MANE Select
- NM_001040716
- dbSNP
- rs752714051
- Type
- single nucleotide variant
- Location
- chr11:66871317 (GRCh38)
- Gene constraint
- LOEUF 0.539 · pLI 0.07 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 90.53 · 10 PDB
- Residue 162
- the biotin carboxylation domain; the atp-grasp domain
Disease context
pyruvate carboxylase deficiency disease — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Pyruvate carboxylase deficiency (Orphanet):
- Inheritance
- Autosomal recessive, Not applicable
- Onset
- Infancy, Neonatal
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- PC p.Ala162= Conflicting classifications of pathogenicity ★ same residue
- PC c.1368+1G>A Likely pathogenic ★★ same condition
- PC c.1826-1G>C Likely pathogenic ★★ same condition
- PC c.1983-116C>T Likely pathogenic ★★ same condition
- PC c.633+2T>C Likely pathogenic ★★ same condition
- PC p.Ala610Thr Pathogenic ★★ same condition
- PC p.Ala812Asp Likely pathogenic ★★ same condition
- PC p.Arg18Ter Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pc-p-ala162val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown